By vgreene, 9 September, 2016 Diversion of ADHD meds is a concern and warrants monitoring sx and refill requests
By vgreene, 9 September, 2016 Consider longer acting med or late afternoon dosing of short-acting med
By vgreene, 9 September, 2016 Consider longer acting med or late afternoon dosing of short-acting med
By vgreene, 9 September, 2016 Prescribe FDA-approved ADHD med w/ pt consent [A/S] and may prescribe behavioral tx [C/R], preferably both
By vgreene, 9 September, 2016 If sx do not improve: Re-eval to confirm dx, assess for coexisting condition, and provide education to improve adherence; reconsider tx plan: Change med/dose,4 or add med approved for adjuvant tx,5 approved for adjuvant tx,5 and/or change behavioral tx
By vgreene, 9 September, 2016 Monitor improvement in core sx3/target goals in objective way whenever possible
By vgreene, 9 September, 2016 Subsequent visits depend on response but should occur at least 2 times/yr until clear that target goals are progressing and sx stabilized, then periodically, as determined by family and treating clinician
By vgreene, 9 September, 2016 F/U monthly until consistent, optimal response observed, and q3mo thereafter during 1st yr of tx
By vgreene, 9 September, 2016 Schedule face-to-face F/U by 4th wk of medication to review response and monitor for ADR, pulse, BP, and wt
